MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, NXTC had -$10,815K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$10,815K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Sales and maturities of marketab...
    • Net proceeds from at-the-market ...
    • Accounts payable
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accrued liabilities and other li...
    • Prepaid expenses and other asset...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-9,796 -9,436 -8,624 -37,784
Depreciation and amortization
283 365 533 1,287
Amortization of premiums and discounts on marketable securities
59 49 46 386
Stock-based compensation
344 435 600 1,951
Noncash operating lease expense
154 151 148 288
Prepaid expenses and other assets
308 -1,623 -1,195 1,716
Accounts payable
1,059 -380 -153 -2,809
Accrued liabilities and other liabilities
4,735 49 -367 -4,016
Lease liabilities
-269 -263 -254 -488
Other long-term liabilities
-36 -35 -34 -66
Net cash used in operating activities
-13,363 -7,638 -6,268 -35,707
Sales and maturities of marketable securities
1,300 6,003 8,700 37,558
Purchases of marketable securities
-0 0 26,705
Net cash provided by investing activities
1,300 6,003 8,700 10,853
Proceeds from issuance of common stock
-20,276 0 2,000
Net proceeds from at-the-market sales
1,234 ---
Proceeds from shares issued under espp
-17 0 19
Proceeds from exercise of stock options
14 ---
Net cash provided by financing activities
1,248 20,293 0 2,019
Net increase (decrease) in cash and cash equivalents
-10,815 18,658 2,432 -22,835
Cash and cash equivalents - beginning of period
25,982 7,324 27,727 -
Cash and cash equivalents - end of period
15,167 25,982 7,324 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Sales and maturitiesof marketable...$1,300K Net proceeds fromat-the-market sales$1,234K Proceeds from exercise ofstock options$14K Net cash provided byinvesting activities$1,300K Net cash provided byfinancing activities$1,248K Net increase(decrease) in cash and cash...-$10,815K Canceled cashflow$2,548K Accounts payable$1,059K Stock-based compensation$344K Depreciation andamortization$283K Noncash operating leaseexpense$154K Net cash used inoperating activities-$13,363K Canceled cashflow$1,840K Net loss-$9,796K Accrued liabilities andother liabilities$4,735K Prepaid expenses andother assets$308K Lease liabilities-$269K Amortization of premiums anddiscounts on marketable...$59K Other long-termliabilities-$36K

NextCure, Inc. (NXTC)

NextCure, Inc. (NXTC)